---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-24-000023"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2024-02-26T23:59:59+00:00"
generated_at: "2026-06-05T15:32:32.118211+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers FY2023 revenue $872M (+65% YoY); Q4 net income $1.2M; guides FY2024 rev $1.17-1.20B

## Summary
- FY2023 revenue $872.0M, up 65% YoY; net loss improved to $(23.5)M from $(65.7)M.
- Q4 2023 revenue $246.6M (+47% YoY); first net income quarter of $1.2M vs $(10.9)M loss.
- Adjusted EBITDA Q4 $20.6M vs $3.9M; FY2023 Adj. EBITDA $49.5M vs $(15.8M) loss.
- Subscribers reached 1.54M, up 48% YoY; monthly online revenue per subscriber $53.
- Guides FY2024 revenue $1.17B-$1.20B; Adj. EBITDA $100M-$120M, beating 2025 target early.

## SEC filing metadata
- accession: 0001773751-24-000023
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2024-02-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/0001773751-24-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/hims-20240226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-24-000023
- JSON: https://secwatch.observer/filing/0001773751-24-000023.json
- Plain text: https://secwatch.observer/filing/0001773751-24-000023.txt

## Key facts
- Earnings Releases
  Hims & Hers Health, Inc. reported the year ended December 31, 2023 results: revenue $872.0 million, net income $(23.5) million. Guidance initiated.
  - Period: the year ended December 31, 2023
  - Revenue: $872.0 million
  - Net income: $(23.5) million
  - Guidance: initiated
  - Result: reported results
  source text: Revenue was $872.0 million for the year ended December 31, 2023 compared to $526.9 million for the year ended December 31, 2022, an increase of 65% year-over-year. • Gross margin was 82% for the year ended December 31, 2023 compared to 78% for the year ended December 31, 2022. • Net loss was $(23.5) million for the year ended December 31, 2023 compared to $(65.7) million for the year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/0001773751-24-000023-index.htm
- Earnings Releases
  Hims & Hers Health, Inc. reported the fourth quarter of 2023 results: revenue $246.6 million, net income $1.2 million. Guidance initiated.
  - Period: the fourth quarter of 2023
  - Revenue: $246.6 million
  - Net income: $1.2 million
  - Guidance: initiated
  - Result: reported results
  source text: Revenue was $246.6 million for the fourth quarter of 2023 compared to $167.2 million for the fourth quarter of 2022, an increase of 47% year-over-year. • Gross margin was 83% for the fourth quarter of 2023 compared to 79% for the fourth quarter of 2022. • Net income was $1.2 million for the fourth quarter of 2023 compared to a net loss of $(10.9) million for the fourth quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/0001773751-24-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.